Skip to main content
. Author manuscript; available in PMC: 2013 Dec 4.
Published in final edited form as: Invest New Drugs. 2009 Jul 2;28(5):10.1007/s10637-009-9279-8. doi: 10.1007/s10637-009-9279-8

Fig. 1.

Fig. 1

Systemic Immune Reaction: Graph depicts percentage of patients developing neutralizing antibodies as a function of time. While 88% of the patients demonstrated an antibody response within the first week, 2 patients only did so after 4 weeks